Finance

Beta
Lists
1541:HKG
ImmuneOnco Biopharmaceuticals(Shngh) Inc
HK$3.12
-1.58%
(-0.050) 1D
Jun 8, 4:09:00 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1541...
Open
HK$3.15
High
HK$3.27
Low
HK$3.03
Mkt. cap
1.35B
Avg. vol.
1.88M
Volume
1.17M
52-wk high
HK$16.80
52-wk low
HK$2.80
EPS
-HK$0.61
No. of employees
202
Open
HK$3.15
High
HK$3.27
Low
HK$3.03
Mkt. cap
1.35B
Avg. vol.
1.88M
Volume
1.17M
52-wk high
HK$16.80
52-wk low
HK$2.80
EPS
-HK$0.61
No. of employees
202
News stories
From sources across the web
About ImmuneOnco Biopharmaceuticals(Shngh) Inc
CEO-
Employees202
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
22.01M
22.01M
55.14M
55.14M
Cost of goods sold
-
-
555.00K
555.00K
Cost of revenue
-
-
555.00K
555.00K
Research and development expenses
84.02M
84.02M
77.12M
77.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
13.63M
13.63M
13.34M
13.34M
Operating expense
97.65M
97.65M
90.46M
90.46M
Total operating expenses
97.65M
97.65M
91.01M
91.01M
Operating income
-75.64M
-75.64M
-35.87M
-35.87M
Other non operating income
-2.50K
-2.50K
4.90M
4.90M
EBT including unusual items
-76.36M
-76.36M
-33.27M
-33.27M
EBT excluding unusual items
-76.19M
-76.19M
-33.47M
-33.47M
Income tax expense
-
-
14.50K
14.50K
Effective tax rate
-
-
-0.04%
-0.04%
Other operating expenses
-
-
-
-
Net income
-76.29M
-76.29M
-33.00M
-33.00M
Net profit margin
-346.68%
-346.68%
-59.84%
-59.84%
Earnings per share
-
-
-
-
Interest and investment income
1.85M
1.85M
1.57M
1.57M
Interest expense
-1.22M
-1.22M
-1.43M
-1.43M
Net interest expenses
630.50K
630.50K
136.00K
136.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-73.52M
-73.52M
-33.84M
-33.84M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more